Document is current
Any future updates will be listed below
-
Authors
Korenfeld, Michael https://orcid.org/0000-0003-1804-5525
Hurcikova, Maria https://orcid.org/0009-0000-1741-5067
Tatsuoka, Kay https://orcid.org/0000-0003-3487-6468
Tomciková, Dana https://orcid.org/0000-0002-9285-7065
Cheetham, Janet https://orcid.org/0000-0003-4603-5375
Kacerik, Marek https://orcid.org/0009-0003-3086-0677
,
-
Funding
Funding for this research was provided by:
Sydnexis Inc
Santen SA
- License Information
-
More Information
Article History
Received: 15 December 2025
Accepted: 5 February 2026
First Online: 23 March 2026
Declarations
:
: Michael Korenfeld, MD, is a paid consultant for Santen Inc and Sydnexis. Maria Hurcikova: no conflicts of interest. Kay Tatsuoka is an employee of Santen Inc. Dana Tomciková: no conflicts of interest. Janet Cheetham is a consultant for Sydnexis, and owns stock in AbbVie, Merck, and Johnson & Johnson. Marek Kacerik: no conflicts of interest.
: The protocol and informed consents/assents were approved by the required institutional review boards or ethics committees, and the study was conducted in accordance with Good Clinical Practice guidelines and tenets of the Declaration of Helsinki. Before any protocol-required procedure, written informed consent was obtained from parents or legal guardians; participants 6 years and above provided self-assent.
